CureVac N.V. (FRA:5CV)
Germany
· Delayed Price · Currency is EUR 2.842
+0.002 (0.07%)
Apr 24, 2025, 8:00 AM CET
CureVac Market Cap
CureVac has a market cap or net worth of €628.87 million as of April 23, 2025. Its market cap has decreased by -0.70% in one year.
Market Cap
628.87M
Enterprise Value
225.60M
Revenue
535.18M
Ranking
n/a
PE Ratio
3.88
Stock Price
€2.84
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 628.87M, a decrease of -92.44%. That is a compound annual growth rate of -42.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 627.88M | -15.02% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.72B |
| Siemens Healthineers AG | 49.89B |
| Fresenius SE & Co. KGaA | 21.97B |
| Bayer Aktiengesellschaft | 20.66B |
| Sartorius Aktiengesellschaft | 13.18B |
| Fresenius Medical Care AG | 12.20B |
| Carl Zeiss Meditec AG | 4.95B |
| Fielmann Group AG | 3.66B |